{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:07:19Z","timestamp":1793848039921,"version":"4.6.1"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41581-026-01094-w","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:05:58Z","timestamp":1781780758000},"page":"635-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The versatile roles of long non-coding RNAs in kidney disease"],"prefix":"10.1038","volume":"22","author":[{"given":"Wai Han","family":"Yiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-1941","authenticated-orcid":false,"given":"Sydney C. W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager, K. J. et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 96, 1048\u20131050 (2019).","journal-title":"Kidney Int."},{"key":"1094_CR2","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ndt\/gfac011","volume":"38","author":"JS Lees","year":"2023","unstructured":"Lees, J. S. et al. The \u2018other\u2019 big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrol. Dial. Transpl. 38, 1071\u20131079 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1094_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis, A. et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 20, 473\u2013485 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1094_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.kint.2024.10.031","volume":"107","author":"I Mimura","year":"2025","unstructured":"Mimura, I., Chen, Z. & Natarajan, R. Epigenetic alterations and memory: key players in the development\/progression of chronic kidney disease promoted by acute kidney injury and diabetes. Kidney Int. 107, 434\u2013456 (2025).","journal-title":"Kidney Int."},{"key":"1094_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1042\/CS20230140","volume":"137","author":"N Rex","year":"2023","unstructured":"Rex, N., Melk, A. & Schmitt, R. Cellular senescence and kidney aging. Clin. Sci. 137, 1805\u20131821 (2023).","journal-title":"Clin. Sci."},{"key":"1094_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1083\/jcb.1.1.59","volume":"1","author":"GE Palade","year":"1955","unstructured":"Palade, G. E. A small particulate component of the cytoplasm. J. Biophys. Biochem. Cytol. 1, 59\u201368 (1955).","journal-title":"J. Biophys. Biochem. Cytol."},{"key":"1094_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0021-9258(19)77302-5","volume":"231","author":"MB Hoagland","year":"1958","unstructured":"Hoagland, M. B., Stephenson, M. L., Scott, J. F., Hecht, L. I. & Zamecnik, P. C. A soluble ribonucleic acid intermediate in protein synthesis. J. Biol. Chem. 231, 241\u2013257 (1958).","journal-title":"J. Biol. Chem."},{"key":"1094_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nature05874","volume":"447","author":"EP Consortium","year":"2007","unstructured":"Consortium, E. P. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799\u2013816 (2007).","journal-title":"Nature"},{"key":"1094_CR9","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","volume":"187","author":"LL Chen","year":"2024","unstructured":"Chen, L. L. & Kim, V. N. Small and long non-coding RNAs: past, present, and future. Cell 187, 6451\u20136485 (2024).","journal-title":"Cell"},{"key":"1094_CR10","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s12013-025-01698-2","volume":"83","author":"X He","year":"2025","unstructured":"He, X. & Li, H. Role of lncRNA in pathogenesis, diagnosis and treatment of chronic kidney disease. Cell Biochem. Biophys. 83, 2703\u20132711 (2025).","journal-title":"Cell Biochem. Biophys."},{"key":"1094_CR11","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1002\/jcp.27203","volume":"234","author":"GL Ren","year":"2019","unstructured":"Ren, G. L., Zhu, J., Li, J. & Meng, X. M. Noncoding RNAs in acute kidney injury. J. Cell Physiol. 234, 2266\u20132276 (2019).","journal-title":"J. Cell Physiol."},{"key":"1094_CR12","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. Gencode 2021. Nucleic Acids Res. 49, D916\u2013D923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"1094_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ncrna.2025.01.004","volume":"11","author":"B Chodurska","year":"2025","unstructured":"Chodurska, B. & Kunej, T. Long non-coding RNAs in humans: classification, genomic organization and function. Noncoding RNA Res. 11, 313\u2013327 (2025).","journal-title":"Noncoding RNA Res."},{"key":"1094_CR14","first-page":"28","volume":"10","author":"CI Brannan","year":"1990","unstructured":"Brannan, C. I., Dees, E. C., Ingram, R. S. & Tilghman, S. M. The product of the H19 gene may function as an RNA. Mol. Cell Biol. 10, 28\u201336 (1990).","journal-title":"Mol. Cell Biol."},{"key":"1094_CR15","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.7150\/ijbs.62573","volume":"17","author":"J Yang","year":"2021","unstructured":"Yang, J., Qi, M., Fei, X., Wang, X. & Wang, K. LncRNA H19: a novel oncogene in multiple cancers. Int. J. Biol. Sci. 17, 3188\u20133208 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"1094_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.gendis.2023.02.008","volume":"10","author":"J Liao","year":"2023","unstructured":"Liao, J. et al. Long noncoding RNA (lncRNA) H19: an essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. Genes. Dis. 10, 1351\u20131366 (2023).","journal-title":"Genes. Dis."},{"key":"1094_CR17","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1042\/CS20210994","volume":"136","author":"D Busscher","year":"2022","unstructured":"Busscher, D., Boon, R. A. & Juni, R. P. The multifaceted actions of the lncRNA H19 in cardiovascular biology and diseases. Clin. Sci. 136, 1157\u20131178 (2022).","journal-title":"Clin. Sci."},{"key":"1094_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/351153a0","volume":"351","author":"MS Bartolomei","year":"1991","unstructured":"Bartolomei, M. S., Zemel, S. & Tilghman, S. M. Parental imprinting of the mouse H19 gene. Nature 351, 153\u2013155 (1991).","journal-title":"Nature"},{"key":"1094_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ncb2521","volume":"14","author":"A Keniry","year":"2012","unstructured":"Keniry, A. et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat. Cell Biol. 14, 659\u2013665 (2012).","journal-title":"Nat. Cell Biol."},{"key":"1094_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/351325a0","volume":"351","author":"G Borsani","year":"1991","unstructured":"Borsani, G. et al. Characterization of a murine gene expressed from the inactive X chromosome. Nature 351, 325\u2013329 (1991).","journal-title":"Nature"},{"key":"1094_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/349038a0","volume":"349","author":"CJ Brown","year":"1991","unstructured":"Brown, C. J. et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349, 38\u201344 (1991).","journal-title":"Nature"},{"key":"1094_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0960-9822(01)00632-7","volume":"12","author":"AH Fox","year":"2002","unstructured":"Fox, A. H. et al. Paraspeckles: a novel nuclear domain. Curr. Biol. 12, 13\u201325 (2002).","journal-title":"Curr. Biol."},{"key":"1094_CR23","volume":"6","author":"E Taiana","year":"2020","unstructured":"Taiana, E. et al. LncRNA NEAT1 in paraspeckles: a structural scaffold for cellular DNA damage response systems? Noncoding RNA 6, 26 (2020).","journal-title":"Noncoding RNA"},{"key":"1094_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104578","volume":"118","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard, S., Dashti, S., Farsi, M. & Taheri, M. HOX transcript antisense RNA: an oncogenic lncRNA in diverse malignancies. Exp. Mol. Pathol. 118, 104578 (2021).","journal-title":"Exp. Mol. Pathol."},{"key":"1094_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-021-00312-4","volume":"27","author":"M Da","year":"2021","unstructured":"Da, M., Zhuang, J., Zhou, Y., Qi, Q. & Han, S. Role of long noncoding RNA taurine-upregulated gene 1 in cancers. Mol. Med. 27, 51 (2021).","journal-title":"Mol. Med."},{"key":"1094_CR26","volume":"6","author":"G Arun","year":"2020","unstructured":"Arun, G., Aggarwal, D. & Spector, D. L. MALAT1 long non-coding RNA: functional implications. Noncoding RNA 6, 22 (2020).","journal-title":"Noncoding RNA"},{"key":"1094_CR27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa2400718","volume":"391","author":"VS Ganesh","year":"2024","unstructured":"Ganesh, V. S. et al. Neurodevelopmental disorder caused by deletion of CHASERR, a lncRNA Gene. N. Engl. J. Med. 391, 1511\u20131518 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1094_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62754-2","volume":"16","author":"G Buonaiuto","year":"2025","unstructured":"Buonaiuto, G. et al. LncRNA HSCHARME is altered in human cardiomyopathies and promotes stem cell-derived cardiomyogenesis via splicing regulation. Nat. Commun. 16, 7880 (2025).","journal-title":"Nat. Commun."},{"key":"1094_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neuroscience.2020.10.028","volume":"455","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. LncRNA BACE1-AS promotes autophagy-mediated neuronal damage through the miR-214-3p\/ATG5 signalling axis in Alzheimer\u2019s disease. Neuroscience 455, 52\u201364 (2021).","journal-title":"Neuroscience"},{"key":"1094_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125913","volume":"26","author":"CW Ho","year":"2025","unstructured":"Ho, C. W., Lee, J. W., Shin, C. H. & Min, K. W. LncRNA-encoded micropeptides: expression validation, translational mechanisms, and roles in cellular metabolism. Int. J. Mol. Sci. 26, 5913 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"1094_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34094-y","volume":"13","author":"P Patraquim","year":"2022","unstructured":"Patraquim, P., Magny, E. G., Pueyo, J. I., Platero, A. I. & Couso, J. P. Translation and natural selection of micropeptides from long non-canonical RNAs. Nat. Commun. 13, 6515 (2022).","journal-title":"Nat. Commun."},{"key":"1094_CR32","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.molcel.2025.05.027","volume":"85","author":"L Zhu","year":"2025","unstructured":"Zhu, L. et al. Hepatic micropeptide modulates mitochondrial RNA processing machinery in hepatocellular carcinoma. Mol. Cell 85, 2303\u20132319.e7 (2025).","journal-title":"Mol. Cell"},{"key":"1094_CR33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152911","volume":"131","author":"Q Ge","year":"2021","unstructured":"Ge, Q. et al. Micropeptide ASAP encoded by LINC00467 promotes colorectal cancer progression by directly modulating ATP synthase activity. J. Clin. Invest. 131, e152911 (2021).","journal-title":"J. Clin. Invest."},{"key":"1094_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01654-1","volume":"21","author":"M Li","year":"2022","unstructured":"Li, M. et al. Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG\/EGFR signaling in renal cell carcinoma. Mol. Cancer 21, 181 (2022).","journal-title":"Mol. Cancer"},{"key":"1094_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick, J. S. et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 24, 430\u2013447 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1094_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","volume":"25","author":"S Delaunay","year":"2024","unstructured":"Delaunay, S., Helm, M. & Frye, M. RNA modifications in physiology and disease: towards clinical applications. Nat. Rev. Genet. 25, 104\u2013122 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"1094_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110726","volume":"108","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Xu, X. & Su, X. Modifications of noncoding RNAs in cancer and their therapeutic implications. Cell Signal. 108, 110726 (2023).","journal-title":"Cell Signal."},{"key":"1094_CR38","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.18632\/aging.102950","volume":"12","author":"P Liu","year":"2020","unstructured":"Liu, P. et al. m6A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145\/FAK pathway. Aging 12, 5280\u20135299 (2020).","journal-title":"Aging"},{"key":"1094_CR39","doi-asserted-by":"publisher","first-page":"14663","DOI":"10.2147\/JIR.S530214","volume":"18","author":"P Guo","year":"2025","unstructured":"Guo, P. et al. MALAT1\u2019s m6A modification by METTL3 promotes pyroptosis and inflammation in sepsis-induced acute kidney injury in mice. J. Inflamm. Res. 18, 14663\u201314678 (2025).","journal-title":"J. Inflamm. Res."},{"key":"1094_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101181","volume":"78","author":"CJ Shi","year":"2025","unstructured":"Shi, C. J. et al. 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis. Drug. Resist. Updat. 78, 101181 (2025).","journal-title":"Drug. Resist. Updat."},{"key":"1094_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.devcel.2021.01.015","volume":"56","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. N6-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles. Dev. Cell 56, 702\u2013715.e8 (2021).","journal-title":"Dev. Cell"},{"key":"1094_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.molcel.2009.01.026","volume":"33","author":"CM Clemson","year":"2009","unstructured":"Clemson, C. M. et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell 33, 717\u2013726 (2009).","journal-title":"Mol. Cell"},{"key":"1094_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09482-6","volume":"10","author":"P Zhang","year":"2019","unstructured":"Zhang, P., Cao, L., Zhou, R., Yang, X. & Wu, M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat. Commun. 10, 1495 (2019).","journal-title":"Nat. Commun."},{"key":"1094_CR44","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/s41588-024-01740-8","volume":"56","author":"EH Gail","year":"2024","unstructured":"Gail, E. H. et al. Inseparable RNA binding and chromatin modification activities of a nucleosome-interacting surface in EZH2. Nat. Genet. 56, 1193\u20131202 (2024).","journal-title":"Nat. Genet."},{"key":"1094_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.1192002","volume":"329","author":"MC Tsai","year":"2010","unstructured":"Tsai, M. C. et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329, 689\u2013693 (2010).","journal-title":"Science"},{"key":"1094_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55539-6","volume":"16","author":"JA Oo","year":"2025","unstructured":"Oo, J. A. et al. Long non-coding RNAs direct the SWI\/SNF complex to cell type-specific enhancers. Nat. Commun. 16, 131 (2025).","journal-title":"Nat. Commun."},{"key":"1094_CR47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117988119","volume":"119","author":"C Zhou","year":"2022","unstructured":"Zhou, C. et al. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2. Proc. Natl Acad. Sci. USA 119, e2117988119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1094_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40243-8","volume":"14","author":"MM Suzuki","year":"2023","unstructured":"Suzuki, M. M. et al. TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation. Nat. Commun. 14, 4521 (2023).","journal-title":"Nat. Commun."},{"key":"1094_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406021","volume":"12","author":"C Yang","year":"2025","unstructured":"Yang, C. et al. The diminution of R-loops generated by lncRNA DSP-AS1 inhibits DSP gene transcription to impede the re-epithelialization during diabetic wound healing. Adv. Sci. 12, e2406021 (2025).","journal-title":"Adv. Sci."},{"key":"1094_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70103","volume":"28","author":"Z Wu","year":"2024","unstructured":"Wu, Z. et al. LncRNA ALMS1-IT1 modulates ferroptosis and immune evasion in colorectal cancer through activating STAT3. J. Cell Mol. Med. 28, e70103 (2024).","journal-title":"J. Cell Mol. Med."},{"key":"1094_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55822-0","volume":"16","author":"A Argoetti","year":"2025","unstructured":"Argoetti, A. et al. lncRNA NORAD modulates STAT3\/STAT1 balance and innate immune responses in human cells via interaction with STAT3. Nat. Commun. 16, 571 (2025).","journal-title":"Nat. Commun."},{"key":"1094_CR52","volume":"9","author":"A Ostini","year":"2023","unstructured":"Ostini, A. & Mourtada-Maarabouni, M. Investigation into the role of long-non-coding RNA MIAT in leukemia. Noncoding RNA 9, 47 (2023).","journal-title":"Noncoding RNA"},{"key":"1094_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02569-x","volume":"41","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. LINC00629 protects osteosarcoma cell from ER stress-induced apoptosis and facilitates tumour progression by elevating KLF4 stability. J. Exp. Clin. Cancer Res. 41, 354 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1094_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2023.2286099","volume":"21","author":"P Malakar","year":"2024","unstructured":"Malakar, P., Shukla, S., Mondal, M., Kar, R. K. & Siddiqui, J. A. The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations. RNA Biol. 21, 1\u201320 (2024).","journal-title":"RNA Biol."},{"key":"1094_CR55","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","volume":"39","author":"V Tripathi","year":"2010","unstructured":"Tripathi, V. et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 39, 925\u2013938 (2010).","journal-title":"Mol. Cell"},{"key":"1094_CR56","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.ncrna.2024.06.002","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. New mechanism of LncRNA: in addition to act as a ceRNA. Noncoding RNA Res. 9, 1050\u20131060 (2024).","journal-title":"Noncoding RNA Res."},{"key":"1094_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/HCO.0000000000001041","volume":"38","author":"A Kohlmaier","year":"2023","unstructured":"Kohlmaier, A., Holdt, L. M. & Teupser, D. Long noncoding RNAs in cardiovascular disease. Curr. Opin. Cardiol. 38, 179\u2013192 (2023).","journal-title":"Curr. Opin. Cardiol."},{"key":"1094_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1324393","volume":"15","author":"M Geng","year":"2024","unstructured":"Geng, M. et al. LncRNA as a regulator in the development of diabetic complications. Front. Endocrinol. 15, 1324393 (2024).","journal-title":"Front. Endocrinol."},{"key":"1094_CR59","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","volume":"25","author":"M Coan","year":"2024","unstructured":"Coan, M., Haefliger, S., Ounzain, S. & Johnson, R. Targeting and engineering long non-coding RNAs for cancer therapy. Nat. Rev. Genet. 25, 578\u2013595 (2024).","journal-title":"Nat. Rev. Genet."},{"key":"1094_CR60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste, E. A. J. et al. Global epidemiology and outcomes of acute kidney injury. Nat. Rev. Nephrol. 14, 607\u2013625 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"1094_CR61","first-page":"1","volume":"2","author":"No author group","year":"2012","unstructured":"No author group Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1\u2013138 (2012).","journal-title":"Kidney Int. Suppl."},{"key":"1094_CR62","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.19209","volume":"3","author":"M Ostermann","year":"2020","unstructured":"Ostermann, M. et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw. Open. 3, e2019209 (2020).","journal-title":"JAMA Netw. Open."},{"key":"1094_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21720-3","volume":"8","author":"M Kolling","year":"2018","unstructured":"Kolling, M. et al. Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia\/reperfusion-injury. Sci. Rep. 8, 3438 (2018).","journal-title":"Sci. Rep."},{"key":"1094_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23881","volume":"35","author":"HY Lu","year":"2021","unstructured":"Lu, H. Y., Wang, G. Y., Zhao, J. W. & Jiang, H. T. Knockdown of lncRNA MALAT1 ameliorates acute kidney injury by mediating the miR-204\/APOL1 pathway. J. Clin. Lab. Anal. 35, e23881 (2021).","journal-title":"J. Clin. Lab. Anal."},{"key":"1094_CR65","first-page":"446","volume":"41","author":"Y Ding","year":"2018","unstructured":"Ding, Y. et al. Mechanism of long non-coding RNA MALAT1 in lipopolysaccharide-induced acute kidney injury is mediated by the miR-146a\/NF-\u03baB signaling pathway. Int. J. Mol. Med. 41, 446\u2013454 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"1094_CR66","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/13880209.2022.2058558","volume":"60","author":"M Luo","year":"2022","unstructured":"Luo, M., Liu, Z., Hu, Z. & He, Q. Quercetin improves contrast-induced acute kidney injury through the HIF-1\u03b1\/lncRNA NEAT1\/HMGB1 pathway. Pharm. Biol. 60, 889\u2013898 (2022).","journal-title":"Pharm. Biol."},{"key":"1094_CR67","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1681\/ASN.0000000000000362","volume":"35","author":"R Xue","year":"2024","unstructured":"Xue, R. et al. Long non-coding RNA NEAT1, NOD-like receptor family protein 3 inflammasome, and acute kidney injury. J. Am. Soc. Nephrol. 35, 998\u20131015 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1094_CR68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5114\/ceji.2022.115628","volume":"47","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Downregulation of lncRNA NEAT1 alleviates sepsis-induced acute kidney injury. Cent. Eur. J. Immunol. 47, 8\u201319 (2022).","journal-title":"Cent. Eur. J. Immunol."},{"key":"1094_CR69","doi-asserted-by":"publisher","first-page":"16273","DOI":"10.1002\/jcb.28909","volume":"120","author":"X Jiang","year":"2019","unstructured":"Jiang, X., Li, D., Shen, W., Shen, X. & Liu, Y. LncRNA NEAT1 promotes hypoxia-induced renal tubular epithelial apoptosis through downregulating miR-27a-3p. J. Cell Biochem. 120, 16273\u201316282 (2019).","journal-title":"J. Cell Biochem."},{"key":"1094_CR70","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1016\/j.ymthe.2022.05.019","volume":"30","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p. Mol. Ther. 30, 3313\u20133332 (2022).","journal-title":"Mol. Ther."},{"key":"1094_CR71","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00430-021-00705-6","volume":"210","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p\/TXNIP axis. Med. Microbiol. Immunol. 210, 121\u2013132 (2021).","journal-title":"Med. Microbiol. Immunol."},{"key":"1094_CR72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10495-022-01730-3","volume":"27","author":"J Liu","year":"2022","unstructured":"Liu, J., Li, X., Yang, J. & Zhang, D. LncRNA ENSMUST_147219 mediates the progression of ischemic acute kidney injury by targeting the miR-221-5p\/IRF6 axis. Apoptosis 27, 531\u2013544 (2022).","journal-title":"Apoptosis"},{"key":"1094_CR73","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1080\/0886022X.2021.1974037","volume":"43","author":"J Huang","year":"2021","unstructured":"Huang, J. & Xu, C. LncRNA MALAT1-deficiency restrains lipopolysaccharide (LPS)-induced pyroptotic cell death and inflammation in HK-2 cells by releasing microRNA-135b-5p. Ren. Fail. 43, 1288\u20131297 (2021).","journal-title":"Ren. Fail."},{"key":"1094_CR74","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.11910","volume":"23","author":"LT Deng","year":"2021","unstructured":"Deng, L. T., Wang, Q. L., Yu, C. & Gao, M. lncRNA PVT1 modulates NLRP3-mediated pyroptosis in septic acute kidney injury by targeting miR-20a-5p. Mol. Med. Rep. 23, 271 (2021).","journal-title":"Mol. Med. Rep."},{"key":"1094_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70305","volume":"39","author":"J Li","year":"2025","unstructured":"Li, J. et al. LncRNA OIP5-AS1\/miR-186-5p\/NLRP3 axis contributes to sepsis-induced kidney injury through enhancing NLRP3 inflammasome activation. J. Biochem. Mol. Toxicol. 39, e70305 (2025).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"1094_CR76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10863-020-09845-5","volume":"52","author":"J Tan","year":"2020","unstructured":"Tan, J., Fan, J., He, J., Zhao, L. & Tang, H. Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p\/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury. J. Bioenerg. Biomembr. 52, 367\u2013376 (2020).","journal-title":"J. Bioenerg. Biomembr."},{"key":"1094_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69323-5","volume":"14","author":"J Hao","year":"2024","unstructured":"Hao, J. et al. LincRNA-p21\/AIF-1\/CMPK2\/NLRP3 pathway promoted inflammation, autophagy and apoptosis of human tubular epithelial cell induced by urate via exosomes. Sci. Rep. 14, 18146 (2024).","journal-title":"Sci. Rep."},{"key":"1094_CR78","doi-asserted-by":"publisher","first-page":"C117","DOI":"10.1152\/ajpcell.00394.2020","volume":"321","author":"H Ling","year":"2021","unstructured":"Ling, H. et al. LncRNA GAS5 inhibits miR-579-3p to activate SIRT1\/PGC-1\u03b1\/Nrf2 signaling pathway to reduce cell pyroptosis in sepsis-associated renal injury. Am. J. Physiol. Cell Physiol. 321, C117\u2013C133 (2021).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1094_CR79","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/CM9.0000000000003552","volume":"139","author":"M Zhang","year":"2026","unstructured":"Zhang, M. et al. LncRNA H19 overexpression protects against acute kidney injury after cardiopulmonary bypass via activating Pink1\/Parkin-mediated mitophagy. Chin. Med. J. 139, 880\u2013890 (2026).","journal-title":"Chin. Med. J."},{"key":"1094_CR80","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1681\/ASN.2020060775","volume":"32","author":"G Haddad","year":"2021","unstructured":"Haddad, G. et al. Renal AAV2-mediated overexpression of long non-coding RNA H19 attenuates ischemic acute kidney injury through sponging of microRNA-30a-5p. J. Am. Soc. Nephrol. 32, 323\u2013341 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1094_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79367-2","volume":"14","author":"S Lin","year":"2024","unstructured":"Lin, S. et al. LncRNA AP001007 protects human renal tubular epithelial HK-2 cells and kidney organoids from LPS-induced injury. Sci. Rep. 14, 28578 (2024).","journal-title":"Sci. Rep."},{"key":"1094_CR82","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"Collaboration, G. B. D. C. K. D","year":"2020","unstructured":"Collaboration, G. B. D. C. K. D Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733 (2020).","journal-title":"Lancet"},{"key":"1094_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy, C. P. Epidemiology of chronic kidney disease: an update 2022. Kidney Int. Suppl. 12, 7\u201311 (2022).","journal-title":"Kidney Int. Suppl."},{"key":"1094_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang, R., Fu, P. & Ma, L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal. Transduct. Target. Ther. 8, 129 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1094_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.586895","volume":"11","author":"S Shi","year":"2020","unstructured":"Shi, S. et al. Knockdown of lncRNA-H19 ameliorates kidney fibrosis in diabetic mice by suppressing miR-29a-mediated EndMT. Front. Pharmacol. 11, 586895 (2020).","journal-title":"Front. Pharmacol."},{"key":"1094_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/13813455.2022.2102655","volume":"130","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. LncRNA H19 deficiency protects against the structural damage of glomerular endothelium in diabetic nephropathy via Akt\/eNOS pathway. Arch. Physiol. Biochem. 130, 401\u2013410 (2024).","journal-title":"Arch. Physiol. Biochem."},{"key":"1094_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05068-1","volume":"13","author":"H Su","year":"2022","unstructured":"Su, H. et al. LncRNA ANRIL mediates endothelial dysfunction through BDNF downregulation in chronic kidney disease. Cell Death Dis. 13, 661 (2022).","journal-title":"Cell Death Dis."},{"key":"1094_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108820","volume":"110","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Silencing long noncoding RNA-CES1P1 suppresses glomerular endothelial cell inflammation in diabetic nephropathy. Int. Immunopharmacol. 110, 108820 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"1094_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40891","volume":"11","author":"L Qian","year":"2025","unstructured":"Qian, L. et al. LncRNA TUG1 mitigates chronic kidney disease through miR-542-3p\/HIF-1\u03b1\/VEGF axis. Heliyon 11, e40891 (2025).","journal-title":"Heliyon"},{"key":"1094_CR90","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/CS20220537","volume":"137","author":"WH Yiu","year":"2023","unstructured":"Yiu, W. H. et al. The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy. Clin. Sci. 137, 317\u2013331 (2023).","journal-title":"Clin. Sci."},{"key":"1094_CR91","doi-asserted-by":"publisher","first-page":"604","DOI":"10.24976\/Discov.Med.202436182.57","volume":"36","author":"P Dong","year":"2024","unstructured":"Dong, P., Zhang, S., Hu, D. J., Hou, R. & Lei, L. LncRNA Meg3 aggravates renal fibrosis caused by unilateral ureteral obstruction in rats by activating the hedgehog pathway. Discov. Med. 36, 604\u2013612 (2024).","journal-title":"Discov. Med."},{"key":"1094_CR92","first-page":"1325","volume":"24","author":"N Li","year":"2020","unstructured":"Li, N., Jia, T. & Li, Y. R. LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c. Eur. Rev. Med. Pharmacol. Sci. 24, 1325\u20131337 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1094_CR93","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/FJC.0000000000001177","volume":"79","author":"X Wu","year":"2022","unstructured":"Wu, X., Fan, D. & Chen, B. LncRNA NEAT1 accelerates the proliferation, oxidative stress, inflammation, and fibrosis and suppresses the apoptosis through the miR-423-5p\/GLIPR2 axis in diabetic nephropathy. J. Cardiovasc. Pharmacol. 79, 342\u2013354 (2022).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"1094_CR94","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s12276-020-0381-5","volume":"52","author":"YL Yang","year":"2020","unstructured":"Yang, Y. L. et al. Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1\/2 signaling pathway. Exp. Mol. Med. 52, 266\u2013280 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1094_CR95","doi-asserted-by":"publisher","first-page":"C292","DOI":"10.1152\/ajpcell.00382.2021","volume":"324","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Huang, C., Duan, Z. B., Chen, Y. X. & Xu, C. Y. LncRNA NEAT1 accelerates renal fibrosis progression via targeting miR-31 and modulating RhoA\/ROCK signal pathway. Am. J. Physiol. Cell Physiol. 324, C292\u2013C306 (2023).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1094_CR96","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1002\/jcp.27770","volume":"234","author":"S Huang","year":"2019","unstructured":"Huang, S. et al. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt\/mTOR signaling pathway. J. Cell Physiol. 234, 11200\u201311207 (2019).","journal-title":"J. Cell Physiol."},{"key":"1094_CR97","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2022.11434","volume":"24","author":"N Zhao","year":"2022","unstructured":"Zhao, N. et al. LncRNA NEAT1\/microRNA-124 regulates cell viability, inflammation and fibrosis in high-glucose-treated mesangial cells. Exp. Ther. Med. 24, 507 (2022).","journal-title":"Exp. Ther. Med."},{"key":"1094_CR98","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/jphp.13280","volume":"72","author":"J Xu","year":"2020","unstructured":"Xu, J., Xiang, P., Liu, L., Sun, J. & Ye, S. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19\/miR-143-3p\/TGF-\u03b21 axis. J. Pharm. Pharmacol. 72, 1101\u20131109 (2020).","journal-title":"J. Pharm. Pharmacol."},{"key":"1094_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111373","volume":"123","author":"HY Li","year":"2024","unstructured":"Li, H. Y. et al. LncRNA H19 accelerates renal fibrosis by negatively regulating the let-7b-5p\/TGF-\u03b2R1\/COL1A1 axis. Cell Signal. 123, 111373 (2024).","journal-title":"Cell Signal."},{"key":"1094_CR100","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ncrna.2024.05.002","volume":"9","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. et al. Up-regulation of long non-coding RNA H19 ameliorates renal tubulointerstitial fibrosis by reducing lipid deposition and inflammatory response through regulation of the microRNA-130a-3p\/long-chain acyl-CoA synthetase 1 axis. Noncoding RNA Res. 9, 1120\u20131132 (2024).","journal-title":"Noncoding RNA Res."},{"key":"1094_CR101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/embor.2009.276","volume":"11","author":"C Margadant","year":"2010","unstructured":"Margadant, C. & Sonnenberg, A. Integrin-TGF-\u03b2 crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 11, 97\u2013105 (2010).","journal-title":"EMBO Rep."},{"key":"1094_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45188-y","volume":"13","author":"W Xia","year":"2023","unstructured":"Xia, W. et al. Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p\/ITGB1 axis. Sci. Rep. 13, 18076 (2023).","journal-title":"Sci. Rep."},{"key":"1094_CR103","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202202012RRR","volume":"37","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Long noncoding RNA AI662270 promotes kidney fibrosis through enhancing METTL3-mediated m6 A modification of CTGF mRNA. FASEB J. 37, e23071 (2023).","journal-title":"FASEB J."},{"key":"1094_CR104","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300146R","volume":"37","author":"F Liu","year":"2023","unstructured":"Liu, F., Cao, Y., Zhang, C. & Su, H. Decreased DANCR contributes to high glucose-induced extracellular matrix accumulation in human renal mesangial cell via regulating the TGF-\u03b2\/Smad signaling. FASEB J. 37, e22926 (2023).","journal-title":"FASEB J."},{"key":"1094_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104518","volume":"116","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Long noncoding RNA-GAS5 retards renal fibrosis through repressing miR-21 activity. Exp. Mol. Pathol. 116, 104518 (2020).","journal-title":"Exp. Mol. Pathol."},{"key":"1094_CR106","doi-asserted-by":"publisher","first-page":"F517","DOI":"10.1152\/ajprenal.00085.2021","volume":"321","author":"YY Zhang","year":"2021","unstructured":"Zhang, Y. Y., Tan, R. Z., Yu, Y., Niu, Y. Y. & Yu, C. LncRNA GAS5 protects against TGF-\u03b2-induced renal fibrosis via the Smad3\/miRNA-142-5p axis. Am. J. Physiol. Renal Physiol. 321, F517\u2013F526 (2021).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1094_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010088","volume":"12","author":"HJ Ho","year":"2022","unstructured":"Ho, H. J. & Shirakawa, H. Oxidative stress and mitochondrial dysfunction in chronic kidney disease. Cells 12, 88 (2022).","journal-title":"Cells"},{"key":"1094_CR108","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","volume":"92","author":"DL Galvan","year":"2017","unstructured":"Galvan, D. L., Green, N. H. & Danesh, F. R. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 92, 1051\u20131057 (2017).","journal-title":"Kidney Int."},{"key":"1094_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.802085","volume":"12","author":"S Liu","year":"2021","unstructured":"Liu, S. & Chong, W. Roles of lncRNAs in regulating mitochondrial dysfunction in septic cardiomyopathy. Front. Immunol. 12, 802085 (2021).","journal-title":"Front. Immunol."},{"key":"1094_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.915031","volume":"13","author":"RA Kowluru","year":"2022","unstructured":"Kowluru, R. A. Long noncoding RNAs and mitochondrial homeostasis in the development of diabetic retinopathy. Front. Endocrinol. 13, 915031 (2022).","journal-title":"Front. Endocrinol."},{"key":"1094_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07107-5","volume":"15","author":"Z Lv","year":"2024","unstructured":"Lv, Z. et al. LncRNA PVT1 induces mitochondrial dysfunction of podocytes via TRIM56 in diabetic kidney disease. Cell Death Dis. 15, 697 (2024).","journal-title":"Cell Death Dis."},{"key":"1094_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03022-7","volume":"11","author":"Q Deng","year":"2020","unstructured":"Deng, Q. et al. Increased long noncoding RNA maternally expressed gene 3 contributes to podocyte injury induced by high glucose through regulation of mitochondrial fission. Cell Death Dis. 11, 814 (2020).","journal-title":"Cell Death Dis."},{"key":"1094_CR113","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1172\/JCI87927","volume":"126","author":"J Long","year":"2016","unstructured":"Long, J. et al. Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy. J. Clin. Invest. 126, 4205\u20134218 (2016).","journal-title":"J. Clin. Invest."},{"key":"1094_CR114","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/15384101.2022.2122286","volume":"22","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Long non-coding RNA FABP5P3\/miR-22 axis improves TGF\u03b21-induced fatty acid oxidation deregulation and fibrotic changes in proximal tubular epithelial cells of renal fibrosis. Cell Cycle 22, 433\u2013449 (2023).","journal-title":"Cell Cycle"},{"key":"1094_CR115","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/ars.2021.0227","volume":"39","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. LINC00355 mediates CTNNBIP1 promoter methylation and promotes endoplasmic reticulum stress-induced podocyte injury in diabetic nephropathy. Antioxid. Redox Signal. 39, 225\u2013240 (2023).","journal-title":"Antioxid. Redox Signal."},{"key":"1094_CR116","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.omtn.2021.10.029","volume":"26","author":"B Li","year":"2021","unstructured":"Li, B. et al. Tubule-specific deletion of LincRNA-p21ameliorates lipotoxic kidney injury. Mol. Ther. Nucleic Acids 26, 1280\u20131290 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1094_CR117","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani, S. et al. Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival. JAMA Netw. Open. 4, e2021869 (2021).","journal-title":"JAMA Netw. Open."},{"key":"1094_CR118","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41585-024-00876-w","volume":"21","author":"C Liao","year":"2024","unstructured":"Liao, C., Hu, L. & Zhang, Q. Von Hippel\u2013Lindau protein signalling in clear cell renal cell carcinoma. Nat. Rev. Urol. 21, 662\u2013675 (2024).","journal-title":"Nat. Rev. Urol."},{"key":"1094_CR119","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/cam4.4679","volume":"11","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma. Cancer Med. 11, 3106\u20133114 (2022).","journal-title":"Cancer Med."},{"key":"1094_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101335","volume":"101","author":"D Xie","year":"2025","unstructured":"Xie, D. et al. The molecular code of kidney cancer: a path of discovery for gene mutation and precision therapy. Mol. Aspects Med. 101, 101335 (2025).","journal-title":"Mol. Aspects Med."},{"key":"1094_CR121","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035938","volume":"10","author":"NS Vasudev","year":"2020","unstructured":"Vasudev, N. S. et al. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open. 10, e035938 (2020).","journal-title":"BMJ Open."},{"key":"1094_CR122","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mc.22926","volume":"58","author":"Y Ye","year":"2019","unstructured":"Ye, Y., Zhang, F., Chen, Q., Huang, Z. & Li, M. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p\/ACVR2B signaling. Mol. Carcinog. 58, 279\u2013292 (2019).","journal-title":"Mol. Carcinog."},{"key":"1094_CR123","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1158\/1541-7786.MCR-17-0762","volume":"16","author":"P Kulkarni","year":"2018","unstructured":"Kulkarni, P. et al. Elevated miR-182-5p associates with renal cancer cell mitotic arrest through diminished MALAT-1 expression. Mol. Cancer Res. 16, 1750\u20131760 (2018).","journal-title":"Mol. Cancer Res."},{"key":"1094_CR124","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/0008-5472.CAN-20-1619","volume":"81","author":"Y Gu","year":"2021","unstructured":"Gu, Y. et al. DMDRMR-mediated regulation of m6A-modified CDK4 by m6A reader IGF2BP3 drives ccRCC progression. Cancer Res. 81, 923\u2013934 (2021).","journal-title":"Cancer Res."},{"key":"1094_CR125","doi-asserted-by":"publisher","first-page":"9503","DOI":"10.1002\/jcp.26849","volume":"233","author":"H He","year":"2018","unstructured":"He, H. et al. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7\/RASL11B signaling. J. Cell Physiol. 233, 9503\u20139515 (2018).","journal-title":"J. Cell Physiol."},{"key":"1094_CR126","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/cdd.2017.74","volume":"24","author":"W Zhai","year":"2017","unstructured":"Zhai, W. et al. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)\/miRNA-143-3p signals. Cell Death Differ. 24, 1502\u20131517 (2017).","journal-title":"Cell Death Differ."},{"key":"1094_CR127","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1038\/onc.2016.19","volume":"35","author":"W Zhai","year":"2016","unstructured":"Zhai, W. et al. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor\/HIF-2\u03b1\/C-MYC axis under hypoxia. Oncogene 35, 4866\u20134880 (2016).","journal-title":"Oncogene"},{"key":"1094_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00902-z","volume":"8","author":"ZD Xiao","year":"2017","unstructured":"Xiao, Z. D. et al. Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat. Commun. 8, 783 (2017).","journal-title":"Nat. Commun."},{"key":"1094_CR129","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2020.10.031","volume":"498","author":"JY Bai","year":"2021","unstructured":"Bai, J. Y. et al. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma. Cancer Lett. 498, 70\u201379 (2021).","journal-title":"Cancer Lett."},{"key":"1094_CR130","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8138","volume":"46","author":"C Jin","year":"2021","unstructured":"Jin, C. et al. Mechanism of tumor-derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1. Oncol. Rep. 46, 187 (2021).","journal-title":"Oncol. Rep."},{"key":"1094_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12191-z","volume":"7","author":"H Katayama","year":"2017","unstructured":"Katayama, H. et al. Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma. Sci. Rep. 7, 12016 (2017).","journal-title":"Sci. Rep."},{"key":"1094_CR132","first-page":"4315","volume":"63","author":"H Wang","year":"2003","unstructured":"Wang, H. et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 63, 4315\u20134321 (2003).","journal-title":"Cancer Res."},{"key":"1094_CR133","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1158\/1535-7163.MCT-17-0925","volume":"17","author":"P Dasgupta","year":"2018","unstructured":"Dasgupta, P. et al. MicroRNA-203 inhibits long noncoding RNA HOTAIR and regulates tumorigenesis through epithelial-to-mesenchymal transition pathway in renal cell carcinoma. Mol. Cancer Ther. 17, 1061\u20131069 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"1094_CR134","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1158\/0008-5472.CAN-14-2931","volume":"75","author":"H Hirata","year":"2015","unstructured":"Hirata, H. et al. Long Noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 75, 1322\u20131331 (2015).","journal-title":"Cancer Res."},{"key":"1094_CR135","first-page":"1113","volume":"41","author":"Z Li","year":"2019","unstructured":"Li, Z., Ma, Z. & Xu, X. Long non-coding RNA MALAT1 correlates with cell viability and mobility by targeting miR-22-3p in renal cell carcinoma via the PI3K\/Akt pathway. Oncol. Rep. 41, 1113\u20131121 (2019).","journal-title":"Oncol. Rep."},{"key":"1094_CR136","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates renal cancer cell migration via cofilin-1. Oncol. Lett. 20, 53 (2020).","journal-title":"Oncol. Lett."},{"key":"1094_CR137","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41581-023-00800-2","volume":"20","author":"NJ Coffey","year":"2024","unstructured":"Coffey, N. J. & Simon, M. C. Metabolic alterations in hereditary and sporadic renal cell carcinoma. Nat. Rev. Nephrol. 20, 233\u2013250 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1094_CR138","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","volume":"26","author":"TK Choueiri","year":"2020","unstructured":"Choueiri, T. K. & Kaelin, W. G. Jr. Targeting the HIF2\u2013VEGF axis in renal cell carcinoma. Nat. Med. 26, 1519\u20131530 (2020).","journal-title":"Nat. Med."},{"key":"1094_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0782-5","volume":"19","author":"Q Chen","year":"2019","unstructured":"Chen, Q. et al. Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1\u03b1. Cancer Cell Int. 19, 128 (2019).","journal-title":"Cancer Cell Int."},{"key":"1094_CR140","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s41388-020-01616-1","volume":"40","author":"B You","year":"2021","unstructured":"You, B. et al. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene 40, 1674\u20131689 (2021).","journal-title":"Oncogene"},{"key":"1094_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00701-6","volume":"8","author":"Q Huang","year":"2017","unstructured":"Huang, Q. et al. Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma. Nat. Commun. 8, 918 (2017).","journal-title":"Nat. Commun."},{"key":"1094_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04898-3","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. DMDRMR promotes angiogenesis via antagonizing DAB2IP in clear cell renal cell carcinoma. Cell Death Dis. 13, 456 (2022).","journal-title":"Cell Death Dis."},{"key":"1094_CR143","doi-asserted-by":"publisher","first-page":"C880","DOI":"10.1152\/ajpcell.00459.2019","volume":"320","author":"YP Guo","year":"2021","unstructured":"Guo, Y. P. et al. Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126\/EGFL7 axis. Am. J. Physiol. Cell Physiol. 320, C880\u2013C891 (2021).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1094_CR144","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41417-021-00339-z","volume":"29","author":"G Wang","year":"2022","unstructured":"Wang, G., Li, H. & Hou, Y. LncRNA MAGI2-AS3 inhibits tumor progression and angiogenesis by regulating ACY1 via interacting with transcription factor HEY1 in clear cell renal cell carcinoma. Cancer Gene Ther. 29, 585\u2013596 (2022).","journal-title":"Cancer Gene Ther."},{"key":"1094_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110954","volume":"113","author":"R Yang","year":"2024","unstructured":"Yang, R. et al. LncRNA MAGI2-AS3 inhibits tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma. Cell Signal. 113, 110954 (2024).","journal-title":"Cell Signal."},{"key":"1094_CR146","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/cbin.11595","volume":"45","author":"P Tian","year":"2021","unstructured":"Tian, P., Wei, J. X., Li, J., Ren, J. K. & Yang, J. J. LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR-129-3p to activate STAT3 and PD-L1. Cell Biol. Int. 45, 1546\u20131560 (2021).","journal-title":"Cell Biol. Int."},{"key":"1094_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216463","volume":"578","author":"L Du","year":"2023","unstructured":"Du, L. et al. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p\/SOX4 axis and activating IFN\u03b3-JAK2-STAT1 pathway. Cancer Lett. 578, 216463 (2023).","journal-title":"Cancer Lett."},{"key":"1094_CR148","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/cas.14611","volume":"111","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Li, X., Zhang, C., Zhang, H. & Huang, Y. LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinoma. Cancer Sci. 111, 3693\u20133704 (2020).","journal-title":"Cancer Sci."},{"key":"1094_CR149","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","volume":"25","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy. Nat. Med. 25, 656\u2013666 (2019).","journal-title":"Nat. Med."},{"key":"1094_CR150","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier, A. J. & Elsawa, S. F. Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci. 22, 6995 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1094_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03173-5","volume":"23","author":"P Xu","year":"2023","unstructured":"Xu, P. et al. LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p\/THBS2\/PI3K-Akt pathway. Cancer Cell Int. 23, 330 (2023).","journal-title":"Cancer Cell Int."},{"key":"1094_CR152","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"1094_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814356","volume":"24","author":"S Boussios","year":"2023","unstructured":"Boussios, S. et al. Exosomes in the diagnosis and treatment of renal cell cancer. Int. J. Mol. Sci. 24, 14356 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1094_CR154","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.7150\/ijbs.70289","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang, W. et al. Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway. Int. J. Biol. Sci. 18, 3209\u20133222 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"1094_CR155","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00957-6","volume":"20","author":"T Shen","year":"2022","unstructured":"Shen, T. et al. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3. Cell Commun. Signal. 20, 152 (2022).","journal-title":"Cell Commun. Signal."},{"key":"1094_CR156","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamaoncol.2023.5269","volume":"10","author":"A Ghoreifi","year":"2024","unstructured":"Ghoreifi, A., Vaishampayan, U., Yin, M., Psutka, S. P. & Djaladat, H. Immune checkpoint inhibitor therapy before nephrectomy for locally advanced and metastatic renal cell carcinoma: a review. JAMA Oncol. 10, 240\u2013248 (2024).","journal-title":"JAMA Oncol."},{"key":"1094_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2713-8","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. Cell Death Dis. 11, 515 (2020).","journal-title":"Cell Death Dis."},{"key":"1094_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-025-01228-5","volume":"38","author":"W Saimaiti","year":"2025","unstructured":"Saimaiti, W., Ma, J., Dilimulati, P. & Wang, Y. Sunitinib-resistant renal cell carcinoma cell-derived exosomes promote facilitation of tumor progression via secretion of the lncRNA SNHG16. Hum. Cell 38, 100 (2025).","journal-title":"Hum. Cell"},{"key":"1094_CR159","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12802-9","volume":"24","author":"Q Tan","year":"2024","unstructured":"Tan, Q. et al. Evaluating trophinin associated protein as a biomarker of prognosis and therapy response in renal cell carcinoma. BMC Cancer 24, 1021 (2024).","journal-title":"BMC Cancer"},{"key":"1094_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07456-9","volume":"16","author":"Y Pan","year":"2025","unstructured":"Pan, Y. et al. STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death Dis. 16, 125 (2025).","journal-title":"Cell Death Dis."},{"key":"1094_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02021-3","volume":"10","author":"P Tian","year":"2024","unstructured":"Tian, P., Wei, J., Li, J., Ren, J. & He, C. An oncogenic role of lncRNA SNHG1 promotes ATG7 expression and autophagy involving tumor progression and sunitinib resistance of renal cell carcinoma. Cell Death Discov. 10, 273 (2024).","journal-title":"Cell Death Discov."},{"key":"1094_CR162","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/0008-5472.CAN-21-3432","volume":"83","author":"Y Pan","year":"2023","unstructured":"Pan, Y. et al. Extracellular vesicle-mediated transfer of LncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma. Cancer Res. 83, 103\u2013116 (2023).","journal-title":"Cancer Res."},{"key":"1094_CR163","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canlet.2021.08.028","volume":"524","author":"M He","year":"2022","unstructured":"He, M. et al. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR\/ER\u03b2\/Hif2-\u03b1 signaling. Cancer Lett. 524, 15\u201328 (2022).","journal-title":"Cancer Lett."},{"key":"1094_CR164","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"1094_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01663-1","volume":"22","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Molecular mechanisms of aging and anti-aging strategies. Cell Commun. Signal. 22, 285 (2024).","journal-title":"Cell Commun. Signal."},{"key":"1094_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126585","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Yu, C. & Li, X. Kidney aging and chronic kidney disease. Int. J. Mol. Sci. 25, 6585 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1094_CR167","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-026-01253-3","author":"AB Herman","year":"2026","unstructured":"Herman, A. B. et al. Molecular damage associated with ageing drives inflammation in cardiovascular disease. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-026-01253-3 (2026).","journal-title":"Nat. Rev. Cardiol."},{"key":"1094_CR168","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/1440-1681.12795","volume":"44","author":"W Xing","year":"2017","unstructured":"Xing, W. et al. Long non-coding RNAs in aging organs and tissues. Clin. Exp. Pharmacol. Physiol. 44, 30\u201337 (2017).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"1094_CR169","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4103\/1673-5374.355751","volume":"18","author":"SAM Sherazi","year":"2023","unstructured":"Sherazi, S. A. M. et al. Molecular hallmarks of long non-coding RNAs in aging and its significant effect on aging-associated diseases. Neural Regen. Res. 18, 959\u2013968 (2023).","journal-title":"Neural Regen. Res."},{"key":"1094_CR170","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08479-8","volume":"23","author":"J Li","year":"2022","unstructured":"Li, J. et al. Predict the role of lncRNA in kidney aging based on RNA sequencing. BMC Genomics 23, 254 (2022).","journal-title":"BMC Genomics"},{"key":"1094_CR171","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.devcel.2017.08.021","volume":"43","author":"X Bao","year":"2017","unstructured":"Bao, X. et al. CSNK1a1 regulates PRMT1 to maintain the progenitor state in self-renewing somatic tissue. Dev. Cell 43, 227\u2013239.e5 (2017).","journal-title":"Dev. Cell"},{"key":"1094_CR172","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11357-021-00460-9","volume":"44","author":"T Kaucsar","year":"2022","unstructured":"Kaucsar, T. et al. Divergent regulation of lncRNA expression by ischemia in adult and aging mice. Geroscience 44, 429\u2013445 (2022).","journal-title":"Geroscience"},{"key":"1094_CR173","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1681\/ASN.0000000000000354","volume":"35","author":"GD Kim","year":"2024","unstructured":"Kim, G. D. et al. Cell type- and age-specific expression of lncRNAs across kidney cell types. J. Am. Soc. Nephrol. 35, 870\u2013885 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1094_CR174","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/stmcls\/sxac054","volume":"40","author":"A Picerno","year":"2022","unstructured":"Picerno, A. et al. The long non-coding RNA HOTAIR controls the self-renewal, cell senescence, and secretion of anti-aging protein \u03b1-Klotho in human adult renal progenitor cells. Stem Cell 40, 963\u2013975 (2022).","journal-title":"Stem Cell"},{"key":"1094_CR175","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10522-023-10091-6","volume":"25","author":"X Guo","year":"2024","unstructured":"Guo, X., Wang, J., Wu, Y., Zhu, X. & Xu, L. Renal aging and mitochondrial quality control. Biogerontology 25, 399\u2013414 (2024).","journal-title":"Biogerontology"},{"key":"1094_CR176","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1089\/ars.2024.0631","volume":"41","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. M6A RNA methylation-mediated TUG1 stability maintains mitochondrial homeostasis during kidney aging by epigenetically regulating PGC1-\u03b1 expression. Antioxid. Redox Signal. 41, 993\u20131013 (2024).","journal-title":"Antioxid. Redox Signal."},{"key":"1094_CR177","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12994","volume":"18","author":"G Lee","year":"2019","unstructured":"Lee, G. et al. PGC-1\u03b1, a potential therapeutic target against kidney aging. Aging Cell 18, e12994 (2019).","journal-title":"Aging Cell"},{"key":"1094_CR178","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-030-92034-0_7","volume":"1363","author":"RE Reggiardo","year":"2022","unstructured":"Reggiardo, R. E., Maroli, S. V. & Kim, D. H. LncRNA biomarkers of inflammation and cancer. Adv. Exp. Med. Biol. 1363, 121\u2013145 (2022).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1094_CR179","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8800358","volume":"2021","author":"JX Sun","year":"2021","unstructured":"Sun, J. X. et al. Construction of a novel immune-related lncRNA pair signature with prognostic significance for kidney clear cell renal cell carcinoma. Dis. Markers 2021, 8800358 (2021).","journal-title":"Dis. Markers"},{"key":"1094_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.890641","volume":"13","author":"K Liu","year":"2022","unstructured":"Liu, K. et al. Systematic investigation of immune-related lncRNA landscape reveals a potential long non-coding RNA signature for predicting prognosis in renal cell carcinoma. Front. Genet. 13, 890641 (2022).","journal-title":"Front. Genet."},{"key":"1094_CR181","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1007\/s00432-023-04700-7","volume":"149","author":"J Bohosova","year":"2023","unstructured":"Bohosova, J. et al. Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma. J. Cancer Res. Clin. Oncol. 149, 7587\u20137600 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1094_CR182","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-022-01037-0","volume":"22","author":"Z Wu","year":"2022","unstructured":"Wu, Z., Huang, X., Cai, M. & Huang, P. Potential biomarkers for predicting the overall survival outcome of kidney renal papillary cell carcinoma: an analysis of ferroptosis-related LNCRNAs. BMC Urol. 22, 152 (2022).","journal-title":"BMC Urol."},{"key":"1094_CR183","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211451","volume":"41","author":"W Ma","year":"2021","unstructured":"Ma, W., Zhong, M. & Liu, X. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma. Biosci. Rep. 41, BSR20211451 (2021).","journal-title":"Biosci. Rep."},{"key":"1094_CR184","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.663263","volume":"11","author":"J Yu","year":"2021","unstructured":"Yu, J. et al. Identification of an m6A-related lncRNA signature for predicting the prognosis in patients with kidney renal clear cell carcinoma. Front. Oncol. 11, 663263 (2021).","journal-title":"Front. Oncol."},{"key":"1094_CR185","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/cam4.3820","volume":"10","author":"J Yu","year":"2021","unstructured":"Yu, J., Mao, W., Xu, B. & Chen, M. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Cancer Med. 10, 2359\u20132369 (2021).","journal-title":"Cancer Med."},{"key":"1094_CR186","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/14737159.2021.1873131","volume":"21","author":"T Ma","year":"2021","unstructured":"Ma, T., Jia, H., Ji, P., He, Y. & Chen, L. Identification of the candidate lncRNA biomarkers for acute kidney injury: a systematic review and meta-analysis. Expert Rev. Mol. Diagn. 21, 77\u201389 (2021).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"1094_CR187","doi-asserted-by":"publisher","first-page":"10521","DOI":"10.1007\/s11033-022-07843-x","volume":"49","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Circulating expression and clinical significance of LncRNA ANRIL in diabetic kidney disease. Mol. Biol. Rep. 49, 10521\u201310529 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"1094_CR188","first-page":"1796","volume":"14","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. Expression of lncRNA KCNQ1Ot1 in diabetic nephropathy and its correlation with MEK\/ERK signaling pathway. Am. J. Transl. Res. 14, 1796\u20131806 (2022).","journal-title":"Am. J. Transl. Res."},{"key":"1094_CR189","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2023114760","volume":"42","author":"A Sparmann","year":"2023","unstructured":"Sparmann, A. & Vogel, J. RNA-based medicine: from molecular mechanisms to therapy. EMBO J. 42, e114760 (2023).","journal-title":"EMBO J."},{"key":"1094_CR190","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137498","volume":"25","author":"R Piergentili","year":"2024","unstructured":"Piergentili, R. & Sechi, S. Non-coding RNAs of mitochondrial origin: roles in cell division and implications in cancer. Int. J. Mol. Sci. 25, 7498 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1094_CR191","doi-asserted-by":"publisher","first-page":"9430","DOI":"10.1073\/pnas.0903086106","volume":"106","author":"VA Burzio","year":"2009","unstructured":"Burzio, V. A. et al. Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells. Proc. Natl Acad. Sci. USA 106, 9430\u20139434 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1094_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040830","volume":"16","author":"M Araya","year":"2024","unstructured":"Araya, M. et al. Knockdown of antisense noncoding mitochondrial RNA reduces tumorigenicity of patient-derived clear cell renal carcinoma cells in an orthotopic xenograft mouse model. Cancers 16, 830 (2024).","journal-title":"Cancers"},{"key":"1094_CR193","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.7150\/jca.38880","volume":"11","author":"V Borgna","year":"2020","unstructured":"Borgna, V. et al. Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors. J. Cancer 11, 1780\u20131791 (2020).","journal-title":"J. Cancer"},{"key":"1094_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155783","volume":"266","author":"B Puri","year":"2025","unstructured":"Puri, B., Majumder, S. & Gaikwad, A. B. LncRNA MALAT1 as a potential diagnostic and therapeutic target in kidney diseases. Pathol. Res. Pract. 266, 155783 (2025).","journal-title":"Pathol. Res. Pract."},{"key":"1094_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118505","volume":"262","author":"L Xu","year":"2020","unstructured":"Xu, L., Hu, G., Xing, P., Zhou, M. & Wang, D. Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1\/miR-370-3p\/HMGB1 axis. Life Sci. 262, 118505 (2020).","journal-title":"Life Sci."},{"key":"1094_CR196","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5114\/ceji.2021.109195","volume":"46","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. Resveratrol alleviates sepsis-induced acute kidney injury by deactivating the lncRNA MALAT1\/MiR-205 axis. Cent. European J. Immunol. 46, 295\u2013304 (2021).","journal-title":"Cent. European J. Immunol."},{"key":"1094_CR197","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/acschembio.8b00807","volume":"14","author":"FA Abulwerdi","year":"2019","unstructured":"Abulwerdi, F. A. et al. Selective small-molecule targeting of a triple helix encoded by the long noncoding RNA, MALAT1. ACS Chem. Biol. 14, 223\u2013235 (2019).","journal-title":"ACS Chem. Biol."},{"key":"1094_CR198","doi-asserted-by":"publisher","first-page":"13242","DOI":"10.1002\/anie.201808823","volume":"57","author":"A Donlic","year":"2018","unstructured":"Donlic, A. et al. Discovery of small molecule ligands for MALAT1 by tuning an RNA-binding scaffold. Angew. Chem. Int. Ed. Engl. 57, 13242\u201313247 (2018).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"1094_CR199","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-0716-1581-2_10","volume":"2348","author":"E Taiana","year":"2021","unstructured":"Taiana, E. et al. In vitro silencing of lncRNAs using LNA GapmeRs. Methods Mol. Biol. 2348, 157\u2013166 (2021).","journal-title":"Methods Mol. Biol."},{"key":"1094_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/nat.2020.0906","volume":"31","author":"Meena","year":"2021","unstructured":"Meena & Lemaitre, M. M. Stereocontrolled oligonucleotides for nucleic acid therapeutics: a perspective. Nucleic Acid. Ther. 31, 1\u20136 (2021).","journal-title":"Nucleic Acid. Ther."},{"key":"1094_CR201","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf778","volume":"53","author":"JK Christensen","year":"2025","unstructured":"Christensen, J. K. et al. Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations. Nucleic Acids Res. 53, gkaf778 (2025).","journal-title":"Nucleic Acids Res."},{"key":"1094_CR202","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.omtn.2022.05.024","volume":"28","author":"KA Doxtader Lacy","year":"2022","unstructured":"Doxtader Lacy, K. A., Liang, X. H., Zhang, L. & Crooke, S. T. RNA modifications can affect RNase H1-mediated PS-ASO activity. Mol. Ther. Nucleic Acids 28, 814\u2013828 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1094_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102416","volume":"35","author":"T Hu","year":"2025","unstructured":"Hu, T. et al. TLyp-1-modified exosome-mediated delivery of circRAPGEF5 ASO inhibits lung adenocarcinoma metastasis via regulating the miR-570-3p\/SPP1 axis. Mater. Today Bio 35, 102416 (2025).","journal-title":"Mater. Today Bio"},{"key":"1094_CR204","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s13346-023-01469-7","volume":"14","author":"S Yu","year":"2024","unstructured":"Yu, S. et al. Anticancer effect of hUC-MSC-derived exosome-mediated delivery of PMO-miR-146b-5p in colorectal cancer. Drug. Deliv. Transl. Res. 14, 1352\u20131369 (2024).","journal-title":"Drug. Deliv. Transl. Res."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01094-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01094-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:02:57Z","timestamp":1786968177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01094-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":204,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01094-w","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"29 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.C.W.T. reports consultancy for Boehringer Ingelheim, Novartis and Travere Therapeutics, Inc.; having received speaker\u2019s honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Everest Medicines, GSK, Novartis, Vantive; advisory or leadership role on KDIGO Executive Committee; and other interests or relationships as President of the Asian Pacific Society of Nephrology.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}